Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Context: Women with polycystic ovary syndrome (PCOS) have an increased risk of cardiovascular disease (CVD), and biomarkers can be used to detect early subclinical CVD. Midregional-pro-adrenomedullin (MR-proADM), midregional-pro-atrial natriuretic peptide (MR-proANP) and copeptin are all associat...
Main Authors: | Signe Frøssing, Malin Nylander, Caroline Kistorp, Sven O Skouby, Jens Faber |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-01-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/7/1/115.full |
Similar Items
-
Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
by: Malin Nylander, et al.
Published: (2017-01-01) -
Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study
by: Dres M, et al.
Published: (2017-03-01) -
Assessment of brain natriuretic peptide and copeptin as correlates of blood pressure in chronic hypertensive pregnant women
by: Chika J. Okwor, et al.
Published: (2022-12-01) -
Cardiovascular Biomarkers in Amniotic Fluid, Umbilical Arterial Blood, Umbilical Venous Blood, and Maternal Blood at Delivery, and Their Reference Values for Full-Term, Singleton, Cesarean Deliveries
by: Martin E. Blohm, et al.
Published: (2019-07-01) -
Red cell distribution width as a prognostic marker for complications of community-acquired pneumonia in children: a comparison with Proadrenomedullin and Copeptin
by: Asmaa N. Moustafa, et al.
Published: (2023-10-01)